Immune checkpoints related-LncRNAs can identify different subtypes of lung cancer and predict immunotherapy and prognosis
Hongpan Zhang(Affiliated Hospital of North Sichuan Medical College), Bangxian Tan(Affiliated Hospital of North Sichuan Medical College), Meihan Liu(North Sichuan Medical University), Lu Cao(Chinese Academy of Sciences), Guobo Du(Affiliated Hospital of North Sichuan Medical College), Xianfu Li(North Sichuan Medical University), Bin Yu(Taiyuan Central Hospital), Yan Gui(First Hospital of Lanzhou University), Xiaojie Ma(North Sichuan Medical University)
Cited by 3
Related Papers
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial
|Radiotherapy and Oncology|2017|104
Methamphetamine potentiates HIV-1 gp120-mediated autophagy via Beclin-1 and Atg5/7 as a pro-survival response in astrocytes
|Cell Death and Disease|2016|43
Research progress on the mechanism of radiation enteritis
|Frontiers in Oncology|2022|42